News and Trends 15 Mar 2018
New Antibiotic for MRSA Infections is Ready for US Clinical Trials
…them from antibiotics. Destiny launched a £15.3M (€16.7M) IPO on the London Stock Exchange’s AIM market in September and the company’s stock price is up by over 3% this morning….